Monoterpenoid Biosynthesis via Enzyme Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The mechanism of stereocontrol in nepetalactone biosynthesis in Nepeta species is not known, and existing technologies do not effectively uncouple the reduction and cyclisation steps in iridoid biosynthesis.
Innovation Solution
The discovery of three cyclases, NEPS1-3, from Nepeta mussinii that are responsible for the stereoselective cyclisation and subsequent oxidation of the activated intermediate 8-oxocitronellyl enol into distinct nepetalactone diastereomers, uncoupling the reduction and cyclisation steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If reduction and cyclisation steps are coupled in the same enzyme active site (canonical terpene synthesis), then the process is simplified and occurs in one step, but stereocontrol of bridgehead carbons cannot be achieved
Solution Approach 1:
The invention divides the coupled reduction-cyclisation process into two separate enzymatic steps: (1) ISY catalyses reduction of 8-oxogeranial to form enolate intermediate, and (2) a separate cyclase enzyme catalyses cyclisation of the enolate to form nepetalactone. This segmentation allows each enzyme to optimise its specific function, with the cyclase providing stereocontrol over bridgehead carbons while ISY handles the reduction step.
2Device complexity
If a single enzyme catalyses both activation and cyclisation (terpene synthase), then the mechanism is simple and direct, but stereochemical variation at bridgehead positions cannot be generated
Solution Approach 1:
The invention segments the single-enzyme mechanism into two specialized enzymes: ISY for activation/reduction and a separate cyclase for stereoselective cyclisation. This allows the system to generate stereochemical diversity at bridgehead positions through the cyclase's specific active site architecture while maintaining relatively simple individual enzyme functions.
Solution Approach 2:
The invention introduces an enolate intermediate as a mediator between the ISY reduction step and the cyclase cyclisation step. This intermediate allows the two enzymatic reactions to be uncoupled yet coordinated, enabling stereocontrol during cyclisation while maintaining pathway efficiency through the reactive enolate species.
3Manufacturing precision
If reduction step is stereoselective (as in CrISY), then enantiomeric control is achieved, but diastereomeric control of bridgehead carbons remains unknown
Solution Approach 1:
The invention segments stereocontrol functions between two enzymes: ISY provides enantiomeric control through stereoselective reduction at the 7-position, while the separate cyclase provides diastereomeric control over bridgehead carbons 4a and 7a. This segmentation reveals that enolate geometry (E/Z isomers) generated by ISY determines which diastereomers form during cyclase-catalysed ring closure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the production of specific nepetalactone stereoisomers, influencing insect repellence and other biological effects, by enabling the separation of activation and cyclisation steps in nepetalactone biosynthesis.
Implementation Method 1
providing an enzyme; and contacting the monoterpenoid precursor with the enzyme under catalytic conditions to produce an monoterpenoid compound
Implementation Method 2
The discovery of three cyclases, NEPS1-3, from Nepeta mussinii that are responsible for the stereoselective cyclisation and subsequent oxidation of the activated intermediate 8-oxocitronellyl enol into distinct nepetalactone diastereomers
Implementation Method 3
stereoselective cyclisation and subsequent oxidation of the activated intermediate 8-oxocitronellyl enol into distinct nepetalactone diastereomers
Data Source
AI summary
The invention relates to enzymes and methods for producing a monoterpenoid compound. In one aspect, the invention is a method for producing a monoterpenoid compound, comprising the steps of (1) providing a monoterpenoid precursor; (2) providing a NEPS enzyme; and (3) contacting the monoterpenoid precursor with the enzyme under catalytic conditions to produce an monoterpenoid compound.